Table 2.
Lesion and brain volume measures in patients and CTRLs.
| AAs | CAs | CTRLs | pa | pb | pc | |
|---|---|---|---|---|---|---|
| T2 LV (mL) | 3.60 ± 3.91 | 3.03 ± 2.44 | - | - | - | 0.508 |
| T1 LV (mL) | 0.57 ± 0.43 | 0.52 ± 0.62 | - | - | - | 0.743 |
| CLs (n) | 8.79 ± 6.53 | 6.60 ± 4.68 | - | - | - | 0.149 |
| CL-V (mL) | 0.33 ± 0.28 | 0.22 ± 0.18 | - | - | 0.072 | |
| NBV (mL) | 1511.37 ± 110.49 | 1485.35 ± 75.52 | 1499.14 ± 84.00 | 0.977 | 0.591 | 0.357 |
| NWMV (mL) | 706.06 ± 56.94 | 693.14 ± 33.70 | 703.09 ± 52.67 | 0.961 | 0.497 | 0.399 |
| NGMV (mL) | 805.31 ± 56.05 | 792.21 ± 41.37 | 796.04 ± 44.06 | 0.910 | 0.796 | 0.354 |
Abbreviations: AAs=African Americans; CA=Caucasians; CL=cortical lesions; CL-V=cortical lesions volume; LV=lesion volume; NBV=normalized brain volume; NWMV=normalized white matter volume; NGMV=normalized grey matter volume.
ANOVA age and gender corrected (AAs vs CTRLs; p<0.05).
ANOVA age and gender corrected (CAs vs CTRLs; p<0.05).
ANOVA age and gender corrected (AAs vs CAs; p<0.05).
All the values are expressed as mean ± SD.